S. K. Reehana et al. 2022. LC and LC-MS/MS Studies for the Characterization of Forced Degradation Products of Tucatinib, a Novel Tyrosine Kinase Inhibitor. Challenges and Advances in Pharmaceutical Research Vol. 10. (Nov. 2022), 37–55. DOI:https://doi.org/10.9734/bpi/capr/v10/4705A.